BPC-157
A gastric-derived peptide studied for accelerated tissue healing and gut repair.
BPC-157 is a synthetic peptide derived from a naturally occurring protein found in human gastric juice. It has gained significant attention in research for its remarkable tissue-healing properties, particularly for tendons, ligaments, muscles, and the gastrointestinal tract. Studies in animal models demonstrate accelerated healing of various tissue types, reduced inflammation, and protective effects on organs.
Key Benefits
Tendon & Ligament Repair
Animal studies show accelerated healing of Achilles tendon, rotator cuff, and MCL injuries with BPC-157 administration.
Gut Healing
Research demonstrates protective effects against NSAID-induced gastric damage, inflammatory bowel conditions, and intestinal permeability.
Muscle Recovery
Studies indicate faster muscle healing after crush injuries and improved recovery from muscle tears in animal models.
Anti-Inflammatory
BPC-157 modulates nitric oxide pathways and reduces systemic inflammation markers in preclinical research.
Neuroprotective Effects
Emerging research suggests protection against dopaminergic neurotoxicity and potential benefits for peripheral nerve regeneration.
Angiogenesis
Promotes formation of new blood vessels at injury sites, improving nutrient delivery to damaged tissue.
Research Dosing Information
Not FDA-approved. Oral bioavailability is debated. Most research uses injectable form. Subcutaneous injection near the injury site is commonly discussed in research contexts.
Research Summary
BPC-157 has been extensively studied in animal models since the early 1990s. Over 100 published studies demonstrate efficacy across multiple tissue types. Key findings include accelerated tendon healing (Achilles, rotator cuff), gastroprotection, anti-inflammatory effects, and angiogenesis promotion. Human clinical data remains limited, with most evidence derived from rodent models. A phase II clinical trial for inflammatory bowel disease has been registered but results are pending.
Safety Considerations
- Not FDA-approved for any medical use.
- Most safety data comes from animal studies with no significant adverse effects reported.
- Human clinical trial data is extremely limited.
- Theoretical concerns about promoting growth in existing tumors due to angiogenic properties.
- Quality and purity of commercially available products vary significantly.
- Consult a healthcare provider before use, especially if you have cancer or autoimmune conditions.
Frequently Asked Questions
Is BPC-157 legal?
BPC-157 is not approved by the FDA for medical use but is available as a research compound. It is not currently a controlled substance. Regulations vary by country.
Can I take BPC-157 orally?
Oral capsules exist, but the bioavailability is debated. Most research uses injectable forms administered subcutaneously near the injury site.
How long does BPC-157 take to work?
In animal studies, effects on healing are typically observed within 1-2 weeks. Individual responses vary, and human clinical data is limited.
Can BPC-157 help with gut issues?
Animal research strongly supports gastroprotective and gut-healing effects, including protection against NSAID damage and reduced intestinal inflammation.
Related Content
This page is for educational and research purposes only. It is not medical advice. Consult a healthcare professional before using any peptide or supplement. None of the statements on this page have been evaluated by the FDA.